February 05, 2020
According to the research report titled ‘Nutrigenomics Testing Market Size By Application (Obesity, Diabetes, Cancer, Cardiovascular Diseases), By Distribution Channel (Hospitals & Clinics, Online Platform), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Japan, China, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE), Application Potential, Competitive Market Share & Forecast, 2019 – 2025’, available at MarketStudyReport.com, the global nutrigenomics testing market is expected to cross USD 800 million by 2025.
According to the report, growing occurrence of obesity among people has led to increased pervasiveness of chronic diseases such as cardiovascular diseases and diabetes which in turn is driving the nutrigenomics testing market growth. Nutrigenomics allows nutritionists to recommend personalized diet for obese people to boost their dietary patterns and control their weight. Moreover, technological advancements pertaining to molecular biology and genomics are further aiding the market expansion. However, strict government regulations regarding the use of nutrigenomics may hinder the market growth.
Based on application spectrum, the report states that diabetes applications of nutrigenomics testing were worth USD 70 million in the year 2018 and are expected to register continuous growth during the forecast period. Nutrigenomics testing helps to understand epigenetic modifications and genetic variations among humans. It also offers early diagnosis of diabetes which is projected to enhance product demand from diabetes applications in the approaching years.
Citing the distribution channel landscape, the hospitals & clinics segment is presumed to expand with a CAGR of 10.5% during the period of 2019-2025. The rising demand for treatment of chronic diseases in hospitals and clinics is facilitating the business scenario. Moreover, industry majors are providing advanced nutrigenomics testing kits to healthcare sector which in turn will propel the growth of this distribution channel.
Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2203968/
Considering the geographical landscape, the report cites that Japan held 35% share in Asia-Pacific nutrigenomics testing industry in the year 2018 and is anticipated to witness constant growth in the subsequent years. Shifting preferences towards personalized diet, high occurrence rates of diabetes, and concentration of key industry players are contributing towards the popularity of nutrigenomics testing kits in Japan.
The prominent companies operating in the nutrigenomics testing market are Sanger Genomics, Xcode Life, Salugen, Pathway Genomics, Metagenics, NutraGene, Interleukin Genetics, GX Sciences, Nutrigenomix, Cura Integrative Medicine, and Holistic Heal.
Frequently Asked Questions (FAQ) :